CHICAGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company...
SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company),...
Median Overall Survival (OS) of 15 months for subjects with complete remission (n=8) Median OS of 2nd Line efficacy evaluable...
JERUSALEM, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the...
THE WOODLANDS, Texas, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will...
PALO ALTO, CALIFORNIA / ACCESS Newswire / August 27, 2025 / Bioz, Inc., a cutting-edge AI platform that transforms research...
Dublin, Ireland--(Newsfile Corp. - August 27, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and...
Ignite delivers a powerful blend of proven botanicals along with our award-winning CBD, designed to help men stay strong, sharp,...
Nearly 50 groups, including CatholicVote, are lobbying Trump to keep marijuana Schedule I - but where is that same passion...
HALIFAX, NOVA SCOTIA / ACCESS Newswire / August 26, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has...
NEWARK, CALIFORNIA / ACCESS Newswire / August 26, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that...
HAMILTON, BERMUDA / ACCESS Newswire / August 26, 2025 / Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB:CYTOF), a company...
Physicians, researchers, and partner institutions across Europe aim to deliver innovative, personalized therapies more quickly Development project focused on a...
As EHDS interconnects EU systems, hospitals call for patch SLAs, SBOM/VEX transparency, and baseline API hardening to curb breach risk....
Treatment follows recent Food and Drug Administration approval of the SetPoint System for treatment of RA, a bioelectronic medicine breakthroughNEW...
Treatment follows recent Food and Drug Administration approval of the SetPoint System for treatment of RA, a bioelectronic medicine breakthroughNEW...
Combined company offers next-generation commercialization model that directly connects life sciences to payers and patients to accelerate access, improve affordability...
Combined company offers next-generation commercialization model that directly connects life sciences to payers and patients to accelerate access, improve affordability...
With veterinary clinic partners across 34 states, Ease is building the first centralized platform for veterinary behavioral medicine while keeping...
In this free webinar, explore recent developments in next-generation antibody-drug conjugates (ADCs) and emerging strategies in ADC conjugation and linker...